These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

579 related items for PubMed ID: 31182527

  • 1. In Vitro Activity of APX001A (Manogepix) and Comparator Agents against 1,706 Fungal Isolates Collected during an International Surveillance Program in 2017.
    Pfaller MA, Huband MD, Flamm RK, Bien PA, Castanheira M.
    Antimicrob Agents Chemother; 2019 Aug; 63(8):. PubMed ID: 31182527
    [Abstract] [Full Text] [Related]

  • 2. Activities of Manogepix and Comparators against 1,435 Recent Fungal Isolates Collected during an International Surveillance Program (2020).
    Pfaller MA, Huband MD, Rhomberg PR, Bien PA, Castanheira M.
    Antimicrob Agents Chemother; 2022 Nov 15; 66(11):e0102822. PubMed ID: 36286491
    [Abstract] [Full Text] [Related]

  • 3. Antimicrobial activity of manogepix, a first-in-class antifungal, and comparator agents tested against contemporary invasive fungal isolates from an international surveillance programme (2018-2019).
    Pfaller MA, Huband MD, Flamm RK, Bien PA, Castanheira M.
    J Glob Antimicrob Resist; 2021 Sep 15; 26():117-127. PubMed ID: 34051400
    [Abstract] [Full Text] [Related]

  • 4. Activities of E1210 and comparator agents tested by CLSI and EUCAST broth microdilution methods against Fusarium and Scedosporium species identified using molecular methods.
    Castanheira M, Duncanson FP, Diekema DJ, Guarro J, Jones RN, Pfaller MA.
    Antimicrob Agents Chemother; 2012 Jan 15; 56(1):352-7. PubMed ID: 22083469
    [Abstract] [Full Text] [Related]

  • 5. Activity of a Long-Acting Echinocandin, Rezafungin, and Comparator Antifungal Agents Tested against Contemporary Invasive Fungal Isolates (SENTRY Program, 2016 to 2018).
    Pfaller MA, Carvalhaes C, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 32015043
    [Abstract] [Full Text] [Related]

  • 6. APX001A In Vitro Activity against Contemporary Blood Isolates and Candida auris Determined by the EUCAST Reference Method.
    Arendrup MC, Chowdhary A, Astvad KMT, Jørgensen KM.
    Antimicrob Agents Chemother; 2018 Oct 24; 62(10):. PubMed ID: 30104264
    [Abstract] [Full Text] [Related]

  • 7. Echinocandin and triazole antifungal susceptibility profiles for clinical opportunistic yeast and mold isolates collected from 2010 to 2011: application of new CLSI clinical breakpoints and epidemiological cutoff values for characterization of geographic and temporal trends of antifungal resistance.
    Pfaller MA, Messer SA, Woosley LN, Jones RN, Castanheira M.
    J Clin Microbiol; 2013 Aug 24; 51(8):2571-81. PubMed ID: 23720791
    [Abstract] [Full Text] [Related]

  • 8. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA, Messer SA, Rhomberg PR, Castanheira M.
    Antimicrob Agents Chemother; 2017 Mar 24; 61(3):. PubMed ID: 28052853
    [Abstract] [Full Text] [Related]

  • 9. In vitro activity of E1210, a novel antifungal, against clinically important yeasts and molds.
    Miyazaki M, Horii T, Hata K, Watanabe NA, Nakamoto K, Tanaka K, Shirotori S, Murai N, Inoue S, Matsukura M, Abe S, Yoshimatsu K, Asada M.
    Antimicrob Agents Chemother; 2011 Oct 24; 55(10):4652-8. PubMed ID: 21825291
    [Abstract] [Full Text] [Related]

  • 10. In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022).
    Pfaller M, Huband M, Bien PA, Carvalhaes CG, Klauer A, Castanheira M.
    Antimicrob Agents Chemother; 2024 Feb 07; 68(2):e0113223. PubMed ID: 38205999
    [Abstract] [Full Text] [Related]

  • 11. Manogepix (APX001A) Displays Potent In Vitro Activity against Human Pathogenic Yeast, but with an Unexpected Correlation to Fluconazole MICs.
    Arendrup MC, Jørgensen KM.
    Antimicrob Agents Chemother; 2020 Jun 23; 64(7):. PubMed ID: 32366708
    [Abstract] [Full Text] [Related]

  • 12. In Vitro Antifungal Activity of Manogepix and Other Antifungal Agents against South African Candida auris Isolates from Bloodstream Infections.
    Maphanga TG, Mpembe RS, Naicker SD, Govender NP, for GERMS-SA.
    Microbiol Spectr; 2022 Feb 23; 10(1):e0171721. PubMed ID: 35196811
    [Abstract] [Full Text] [Related]

  • 13. In Vitro and In Vivo Evaluation of the Antifungal Activity of APX001A/APX001 against Candida auris.
    Hager CL, Larkin EL, Long L, Zohra Abidi F, Shaw KJ, Ghannoum MA.
    Antimicrob Agents Chemother; 2018 Mar 23; 62(3):. PubMed ID: 29311065
    [Abstract] [Full Text] [Related]

  • 14. Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010-2012).
    Pfaller MA, Messer SA, Jones RN, Castanheira M.
    J Antibiot (Tokyo); 2015 Sep 23; 68(9):556-61. PubMed ID: 25899126
    [Abstract] [Full Text] [Related]

  • 15. In Vitro Activity of Manogepix (APX001A) and Comparators against Contemporary Molds: MEC Comparison and Preliminary Experience with Colorimetric MIC Determination.
    Jørgensen KM, Astvad KMT, Arendrup MC.
    Antimicrob Agents Chemother; 2020 Jul 22; 64(8):. PubMed ID: 32513793
    [Abstract] [Full Text] [Related]

  • 16. Isavuconazole, micafungin, and 8 comparator antifungal agents' susceptibility profiles for common and uncommon opportunistic fungi collected in 2013: temporal analysis of antifungal drug resistance using CLSI species-specific clinical breakpoints and proposed epidemiological cutoff values.
    Pfaller MA, Rhomberg PR, Messer SA, Jones RN, Castanheira M.
    Diagn Microbiol Infect Dis; 2015 Aug 22; 82(4):303-13. PubMed ID: 25986029
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Pfaller MA, Duncanson F, Messer SA, Moet GJ, Jones RN, Castanheira M.
    Antimicrob Agents Chemother; 2011 Nov 22; 55(11):5155-8. PubMed ID: 21844312
    [Abstract] [Full Text] [Related]

  • 18. In vitro activities of posaconazole, fluconazole, itraconazole, voriconazole, and amphotericin B against a large collection of clinically important molds and yeasts.
    Sabatelli F, Patel R, Mann PA, Mendrick CA, Norris CC, Hare R, Loebenberg D, Black TA, McNicholas PM.
    Antimicrob Agents Chemother; 2006 Jun 22; 50(6):2009-15. PubMed ID: 16723559
    [Abstract] [Full Text] [Related]

  • 19. In vitro antifungal activities of isavuconazole (BAL4815), voriconazole, and fluconazole against 1,007 isolates of zygomycete, Candida, Aspergillus, Fusarium, and Scedosporium species.
    Guinea J, Peláez T, Recio S, Torres-Narbona M, Bouza E.
    Antimicrob Agents Chemother; 2008 Apr 22; 52(4):1396-400. PubMed ID: 18212101
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of APX001A against rare moulds using EUCAST and CLSI methodologies.
    Rivero-Menendez O, Cuenca-Estrella M, Alastruey-Izquierdo A.
    J Antimicrob Chemother; 2019 May 01; 74(5):1295-1299. PubMed ID: 30753499
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.